Sponsor:
Zakłady Farmaceutyczne Polpharma S.A.
ul. Pelplińska 19, 83-200 Starogard Gdański
RAM-AML-IND

A prospective, non-interventional, multicentre study to assess the efficacy and safety of triple therapy with ramipril, amlodipine and indapamide in patients with hypertension uncontrolled with double therapy.

Dear Madam or Sir,
We would like to invite you to participate in a multicentre, observational study on the treatment of arterial hypertension. The registration and login panel for the eCRF system is available on the right.
bg
Biostat Sp. z o.o. is responsible
for the comprehensive
implementation of the study.
Biostat Sp. z o.o.
Kowalczyka 17, 44-206 Rybnik
phone 530 900 803 @ [email protected]